Omega-3 fatty acids and Oxycodone drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Omega-3 fatty acids (dha (docosahexaenoic acid)) and Oxycodone (oxycodone hydrochloride). Common drug interactions include abdominal distension among females and cardiac failure among males.
The phase IV clinical study analyzes what interactions people have when they take Omega-3 fatty acids and Oxycodone. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Omega-3 fatty acids?
Omega-3 fatty acids has active ingredients of dha (docosahexaenoic acid). It is often used in high blood cholesterol. eHealthMe is studying from 285 Omega-3 fatty acids users. Check the latest studies of Omega-3 fatty acids.
What is Oxycodone?
Oxycodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 162,592 Oxycodone users. Check the latest studies of Oxycodone.
12 people who take Omega-3 fatty acids and Oxycodone together, and have interactions are studied.

What are the common drug interactions of Omega-3 Fatty Acids and Oxycodone, by gender? *:
female:
- Abdominal distension
- Anaemia (lack of blood)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Bleeding time prolonged
- Blood bilirubin increased
- Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
- Chills (felling of cold)
- Diarrhoea
- Disease progression
- Dry skin
male:
- Cardiac failure
- Overdose
- Abdominal adhesions (inflammation of abdomen)
- Abdominal pain lower
- Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
- Cardiac failure chronic
- Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Diarrhoea
- Drug ineffective
What are the common drug interactions of Omega-3 Fatty Acids and Oxycodone, by age (0-1 to 60+)? *:
0-1:
- Radiation necrosis (death of cell due to radiation)
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Fatigue (feeling of tiredness)
- Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
- Constipation
- Dizziness
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Malignant neoplasm progression (cancer tumour came back)
- Night sweats (sweating in night)
- Rectal polyp (fleshy growth occurring on the lining of the colon)
- Abdominal distension
- Bleeding time prolonged
60+:
- Cardiac failure
- Overdose
- Renal failure acute (rapid kidney dysfunction)
- Tremor (trembling or shaking movements in one or more parts of your body)
- Anaemia (lack of blood)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
- Cardiac failure chronic
- Chills (felling of cold)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
What are the existing conditions these people have? *
- High Blood Pressure: 4 people, 33.33%
- Asthma: 3 people, 25.00%
- Back Pain: 3 people, 25.00%
- Cardiac Failure Congestive: 3 people, 25.00%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 25.00%
- Stress And Anxiety: 3 people, 25.00%
- Depression: 3 people, 25.00%
- Hypotension (abnormally low blood pressure): 3 people, 25.00%
- Neuropathy Peripheral (surface nerve damage): 3 people, 25.00%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 16.67%
* Approximation only. Some reports may have incomplete information.
Do you take Omega-3 fatty acids and Oxycodone?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Omega-3 fatty acids (285 reports)
- Oxycodone (162,592 reports)
Browse all drug interactions of Omega-3 fatty acids and Oxycodone:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Omega-3 fatty acids:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Oxycodone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Omega-3 fatty acids and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Oxycodone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on dha (docosahexaenoic acid) and oxycodone hydrochloride (the active ingredients of Omega-3 fatty acids and Oxycodone, respectively), and Omega-3 fatty acids and Oxycodone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Keppra cause Personality Disorder? - now
- Could Keppra cause Dysphoria? - 6 seconds ago
- Drug interactions of Valproate Sodium and Ludiomil - 8 seconds ago
- Mobic vs. Sulindac, side effect and effectiveness comparison - 12 seconds ago
- Could Keppra cause Hoarseness Or Changing Voice? - 13 seconds ago
- Could Acetaminophen cause Anaemia Macrocytic? - 15 seconds ago
- Drug interactions of Lovastatin and Levaquin - 15 seconds ago
- Could Gabapentin cause Urinary Tract Infection Pseudomonal? - 18 seconds ago
- Could Keppra cause Learning Disability? - 21 seconds ago
- Drug interactions of Magnevist and Mirtazapine - 25 seconds ago